Browse All

Current Filters

CLEAR FILTER x

TITLE

Baseline Characteristics for INFRONT-3: A Phase 3 Double-Blind, Placebo-Controlled 96-Week Study Evaluating Latozinemab in FTD-GRN

Author:Carter, Lawrence   Borroni, Barbara   Mummery, Catherine   Le Ber, Isabelle   Boeve, Bradley   Boxer, Adam   Smithey, Megan   Chow, Tiffany   Huang, Julie   Guizzetti, Leonardo   Salvadore, Giacomo   Romano, Gary   

Session Name:P8: Aging, Dementia, and Behavioral Neurology: Non-AD Treatments  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P8.005  

Author Institution:Alector, South San Francisco, CA  

Challenges Facing Caregivers of Individuals Diagnosed With Frontotemporal Dementia in the United States

Author:Mausisa, Grace   de Bruin, Annick   Chenette, Devon   Gorky, Susan   Chow, Tiffany   

Session Name:P11: Aging, Dementia, and Behavioral Neurology: Co-morbidities, Complications, and Case Reports of Behavioral Neurology  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P11.009  

Author Institution:Alector, South San Francisco, CA  Center for Information and Study on Clinical Research Participation, Boston, MA  Alector, Castle Rock, CO  

Exploring Quality of Life Impact Reported by Caregivers in the FTD Insights Survey

Author:Chenette, Devon   McCaughey, Stella   Reinecker, Robert   Milliard, Carrie   Dacks, Penny   Chow, Tiffany   

Session Name:P11: Aging, Dementia, and Behavioral Neurology: Co-morbidities, Complications, and Case Reports of Behavioral Neurology  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P11.010  

Author Institution:Alector, South San Francisco, CA  The FTD Disorders Registry, Scarborough, ME  AFTD, King of Prussia, PA